Activation of matrix metalloproteinase (MMP)-2 by membrane type 1-MMP and abnormal immunolocalization of the basement membrane components laminin and type IV collagen in canine spontaneous hemangiosarcomas

Histology and Histopathology

Volumn 24, Issue 4, 2009, Pages 437-446

  Murakami, M ^a   Sakai, Hiroki ^a   Kodama, A ^a   Yanai, T ^a   Mori, T ^a   Maruo, K ^a   Masegi, T ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

Basement membrane; Dog; Hemangiosarcoma; MMP

Indexed keywords

COLLAGEN TYPE 4; GELATINASE A; INTERSTITIAL COLLAGENASE; LAMININ; GELATINASE B; MATRIX METALLOPROTEINASE 14; PROCOLLAGEN;

ANGIOSARCOMA; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CELL SURFACE; CONTROLLED STUDY; CYTOPLASM; DOG; ENZYME ACTIVATION; ENZYME ACTIVITY; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; IMMUNOREACTIVITY; MACROPHAGE; NEUTROPHIL; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; ZYMOGRAPHY; ANIMAL; ANIMAL DISEASE; DOG DISEASE; ENDOTHELIUM CELL; ENZYMOLOGY; GRANULATION TISSUE; HEMANGIOMA; METABOLISM; PATHOLOGY;

CANIS FAMILIARIS;

ANIMALS; BASEMENT MEMBRANE; COLLAGEN TYPE IV; DOG DISEASES; DOGS; ENDOTHELIAL CELLS; GRANULATION TISSUE; HEMANGIOMA; HEMANGIOSARCOMA; LAMININ; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PROCOLLAGEN;

EID: 63449099628     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Amo Y., Masuzawa M., Hamada Y. and Katsuoka K. (2001). Expression of vascular endothelial growth factor in a human hemangiosarcoma cell line (ISO-HAS). Arch. Dermatol. Res. 293, 296-301.
2. Boudreau N., Andrews C., Srebrow A., Ravanpay A. and Cheresh D.A. (1997). Induction of the angiogenic phenotype by Hox D3. J. Cell Biol. 139, 257-264.
3. Brassard D.L., Maxwell E., Malkowski M., Nagabhushan T.L., Kumar C.C. and Armstrong L. (1999). Integrin alpha(v)beta(3)-mediated activation of apoptosis. Exp. Cell Res. 251, 33-45.
4. Brooks P.C., Montgomery A.M., Rosenfeld M., Reisfeld R.A., Hu T., Klier G. and Cheresh D.A. (1994). Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79, 1157-1164.
5. Brown N.O., Patnaik A.K. and MacEwen E.G. (1985). Canine hemangiosarcoma: retrospective analysis of 104 cases. J. Am. Vet. Med. Assoc. 186, 56-58.
6. Clifford C.A., Mackin A.J. and Henry C.J. (2000). Treatment of canine hemangiosarcoma: 2000 and beyond. J. Vet. Intern. Med. 14, 479-485.
7. Conway E.M., Collen D. and Carmeliet P. (2001). Molecular mechanisms of blood vessel growth. Cardiovasc. Res. 49, 507-521.
8. Dickerson E.B., Thomas R., Fosmire S.P., Lamerato-Kozicki A.R., Bianco S.R., Wojcieszyn J.W., Breen M., Helfand S.C. and Modiano J.F. (2005). Mutations of phosphatase and tensin homolog deleted from chromosome 10 in canine hemangiosarcoma. Vet. Pathol. 42, 618-632.
9. Egeblad M. and Werb Z. (2002). New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2, 161-174.
10. Evans R.D. and Itoh Y. (2007). Analyses of MT1-MMP activity in cells. Methods Mol. Med. 135, 239-249.
11. Fedok F.G., Levin R.J., Maloney M.E. and Tipirneni K. (1999). Angiosarcoma: current review. Am. J. Otolaryngol. 20, 223-231.
12. Fosmire S.P., Dickerson E.B., Scott A.M., Bianco S.R., Pettengill M.J., Meylemans H., Padilla M., Frazer-Abel A.A., Akhtar N., Getzy D.M., Wojcieszyn J., Breen M., Helfand S.C. and Modiano J.F. (2004). Canine malignant hemangiosarcoma as a model of primitive angiogenic endothelium. Lab. Invest. 84, 562-572.
13. Freitas S., Meduri G., Le Nestour E., Bausero P. and Perrot-Applanat M. (1999). Expression of metalloproteinases and their inhibitors in blood vessels in human endometrium. Biol. Reprod. 61, 1070-1082.
14. Garcia-Barros M., Paris F., Cordon-Cardo C., Lyden D., Rafii S., Haimovitz-Friedman A., Fuks Z. and Kolesnick R. (2003). Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300, 1155-1159.
15. Goldschmidt M.H. and Hendrick M.J. (2002). TUMORS in Domestic Animals, 4th. Meuten, D. J (ed). Iowa State Press, Ames, IA, pp 101-102.
16. Hammer A.S., Couto C.G., Filppi J., Getzy D. and Shank K. (1991). Efficacy and toxicity of VAC chemotherapy (vincristine, doxorubicin, and cyclophosphamide) in dogs with hemangiosarcoma. J. Vet. Intern. Med. 5, 160-166.
17. Hendrick M.J., Mahaffey E.A., Moore F.M., Vos J.H. and Walder E.J. (1998) Histological classification of mesenchymal tumors of skin and soft tissues of domestic animals. Armed Forces Institute of Pathology. Washington, D.C.
18. Hirayama K., Yokota H., Onai R., Kobayashi T., Kumata T., Kihara K., Okamoto M., Sako T., Nakade T., Izumisawa Y. and Taniyama H. (2002). Detection of matrix metalloproteinases in canine mammary tumours: analysis by immunohistochemistry and zymography. J Comp. Pathol. 127, 249-256.
19. Holmbeck K., Bianco P., Caterina J., Yamada S., Kromer M., Kuznetsov S.A., Mankani M., Robey P.G., Poole A.R., Pidoux I., Ward J.M. and Birkedal-Hansen H. (1999). MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99, 81-92.
20. Iivanainen E., Kahari V.M., Heino J. and Elenius K. (2003). Endothelial cell-matrix interactions. Microsc. Res. Tech. 60, 13-22.
21. Itakura E., Yamamoto H., Oda Y. and Tsuneyoshi M. (2008). Detection and characterization of vascular endothelial growth factors and their receptors in a series of angiosarcomas. J. Surg. Oncol. 97, 74-81.
22. Kayano K., Shimada T., Shinomiya T., Nakai S., Hisa Y., Aoki T., Seiki M. and Okada Y. (2004). Activation of pro-MMP-2 mediated by MT1-MMP in human salivary gland carcinomas: possible regulation of pro-MMP-2 activation by TIMP-2. J. Pathol. 202, 403-411.
23. Keshet E. and Ben-Sasson S.A. (1999). Anticancer drug targets: approaching angiogenesis. J. Clin. Invest. 104, 1497-1501.
24. Lamerato-Kozicki A.R., Helm K.M., Jubala C.M., Cutter G.C. and Modiano J.F. (2006). Canine hemangiosarcoma originates from hematopoietic precursors with potential for endothelial differentiation. Exp. Hematol. 34, 870-878.
25. Loukopoulos P., Mungall M.B., Straw R.C., Thornton J.R. and Robinson W.F. (2003). Matrix metalloproteinase-2 and -9 involvement in canine tumors. Vet. Pathol. 40, 382-394.
26. Lowry O.H., Rosebrough N.J., Farr A.L. and Randall R.J. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
27. Maluf D., Cotterell A., Clark B., Stravitz T., Kauffman H.M. and Fisher R.A. (2005). Hepatic angiosarcoma and liver transplantation: case report and literature review. Transplant. Proc. 37, 2195-2199.
28. Malyankar U.M., Scatena M., Suchland K.L., Yun T.J., Clark E.A. and Giachelli C.M. (2000). Osteoprotegerin is an alpha vbeta 3-induced, NF-kappa B-dependent survival factor for endothelial cells. J. Biol. Chem. 275, 20959-20962.
29. McDonnell S., Morgan M. and Lynch C. (1999). Role of matrix metalloproteinases in normal and disease processes. Biochem. Soc. Trans. 27, 734-740.
30. Meis-Kindblom J.M. and Kindblom L.G. (1998). Angiosarcoma of soft tissue: a study of 80 cases. Am. J. Surg. Pathol. 22, 683-697.
31. Murphy G. and Crabbe T. (1995). Gelatinases A and B. Methods Enzymol. 248, 470-484.
32. Myers C., Charboneau A. and Boudreau N. (2000). Homeobox B3 promotes capillary morphogenesis and angiogenesis. J. Cell Biol. 148, 343-351.
33. Naka N., Tomita Y., Nakanishi H., Araki N., Hongyo T., Ochi T. and Aozasa K. (1997). Mutations of p53 tumor-suppressor gene in angiosarcoma. Int. J. Cancer 71, 952-955.
34. Neuhauser T.S., Derringer G.A., Thompson L.D., Fanburg-Smith J.C., Miettinen M., Saaristo A. and Abbondanzo S.L. (2000). Splenic angiosarcoma: a clinicopathologic and immunophenotypic study of 28 cases. Mod. Pathol. 13, 978-987.
35. Nguyen M., Arkell J. and Jackson C.J. (2001). Human endothelial gelatinases and angiogenesis. Int. J. Biochem. Cell Biol. 33, 960-970.
36. Papparella S., Restucci B., Paciello O. and Maiolino P. (2002). Expression of matrix metalloprotease-2 (MMP-2) and the activator membrane type 1 (MT1-MMP) in canine mammary carcinomas. J. Comp. Pathol. 126, 271-276.
37. Prymak C., McKee L.J., Goldschmidt M.H. and Glickman L.T. (1988). Epidemiologic, clinical, pathologic, and prognostic characteristics of splenic hemangiosarcoma and splenic hematoma in dogs: 217 cases (1985). J. Am. Vet. Med. Assoc. 193, 706-712.
38. Soini Y., Hurskainen T., Hoyhtya M., Oikarinen A. and Autio-Harmainen H. (1994). 72 KD and 92 KD type IV collagenase, type IV collagen, and laminin mRNAs in breast cancer: a study by in situ hybridization. J. Histochem. Cytochem. 42, 945-951.
39. Sorenmo K., Duda L., Barber L., Cronin K., Sammarco C., Usborne A., Goldschmidt M. and Shofer F. (2000). Canine hemangiosarcoma treated with standard chemotherapy and minocycline. J. Vet. Intern. Med. 14, 395-398.
40. Sounni N.E., Devy L., Hajitou A., Frankenne F., Munaut C., Gilles C., Deroanne C., Thompson E.W., Foidart J.M. and Noel A. (2002). MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression. FASEB J. 16, 555-564.
41. Sternlicht M.D. and Werb Z. (2001). How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17, 463-516.
42. Tate G., Suzuki T. and Mitsuya T. (2007). Mutation of the PTEN gene in a human hepatic angiosarcoma. Cancer Genet. Cytogenet. 178, 160-162.
43. Thompson W.M., Levy A.D., Aguilera N.S., Gorospe L. and Abbott R.M. (2005). Angiosarcoma of the spleen: imaging characteristics in 12 patients. Radiology 235, 106-115.
44. Van der Flier A. and Sonnenberg A. (2001). Function and interactions of integrins. Cell Tissue Res. 305, 285-298.
45. Wary K.K. (2003). Signaling through Raf-1 in the neovasculature and target validation by nanoparticles. Mol. Cancer. 2, 27.
46. Yonemaru K., Sakai H., Murakami M., Kodama A., Mori T., Yanai T., Maruo K. and Masegi T. (2007). The significance of p53 and retinoblastoma pathways in canine hemangiosarcoma. J. Vet. Med. Sci. 69, 271-278.
47. Yonemaru K., Sakai H., Murakami M., Yanai T. and Masegi T. (2006). Expression of vascular endothelial growth factor, basic fibroblast growth factor, and their receptors (flt-1, flk-1, and flg-1) in canine vascular tumors. Vet. Pathol. 43, 971-980.
48. Zhou Z., Apte S.S., Soininen R., Cao R., Baaklini G.Y., Rauser R.W., Wang J., Cao Y. and Tryggvason K. (2000). Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc. Natl. Acad. Sci. USA 97, 4052-4057.